FORT WORTH, TX – By best estimates, patients who don’t adhere to their prescribed medication plans cost the U.S. health care system between $100 billion and $300 billion annually in likely avoidable healthcare services. These shocking numbers include the impact of the 20‐30 percent of prescriptions that patients abandon at pharmacies. To tackle this widespread, preventable issue, PDX Inc. and DrFirst are pleased to announce a joint effort to provide pharmacies with solutions designed to boost first-fill rates for new prescriptions and increase medication adherence.
“Prescriptions go unfilled in our country due to financial concerns, a lack of understanding of why a drug is needed or sometimes just forgetting to get a script filled,” said G. Cameron Deemer, president of DrFirst. “Our partnership with PDX will focus on eliminating economic, behavioral and clinical barriers to getting patients on their therapies … and keeping them there. We are excited to work together to bend the curve on prescription abandonment and help patients improve their health in the process.”
DrFirst is the nation’s leading provider of pricing transparency, e‐prescribing, and medication management solutions. They provide pharmacies with real-time access to patient data at the point of care to improve communication and collaboration across the patient’s care team. The company’s unique ability to leverage relationships across healthcare gives pharmacies the inter‐industry connectivity needed to improve patient care and safety, enhance pharmacy workflow and grow in‐store profitability.
Leveraging its extensive experience and innovative pharmacy technology, PDX will work with DrFirst to introduce technology solutions to pharmacies aimed at increasing the fill rate of new prescriptions, increasing sales for pharmacies and improving patient lives. In addition to realizing increased revenue from new prescription sales, bringing more patients into the pharmacy means more opportunity for front-of-store sales.
“We look forward to working with DrFirst to help resolve an issue that is so prevalent in pharmacy today,” PDX Vice President of Clinical Development Trey Ferguson said. “By bringing together the connections and expertise DrFirst has on the prescriber side with PDX’s expertise on the pharmacy side, we believe we can effectively address primary medication non-adherence for the betterment of patient lives and for the pharmacy industry.”
The collaboration between PDX and DrFirst will keenly focus on reducing primary non-adherence, that is, driving first-fill rates for new prescriptions, to improve patient outcomes. The two companies will work together to help close the gap in patient care and drive patient engagement while also asserting the role of pharmacy in the healthcare journey.
About PDX Inc.
Pharmacies and health systems across the U.S. benefit from technologies and services provided by PDX Inc. PDX has developed a well-adopted, patient-centric Enterprise Pharmacy System, as well as a comprehensive suite of products and services that range from robust data analytics to revenue cycle management, a flexible clinical services platform and more. PDX continues to build on its 30-plus-year commitment to excellence in healthcare and optimal patient outcomes by delivering unmatched pharmacy and clinical technology solutions. For more information, please visit pdxinc.com or connect with us @PDXInc.
About DrFirst
DrFirst, the nation’s leading provider of e-prescribing, price transparency and medication management solutions, enables stakeholders across the healthcare industry to use comprehensive real-time data and connectivity to increase their patient safety ratings, efficiency and profitability. Today, more than 220,000 healthcare professionals, 75,000 prescribers, 67,000 pharmacies, hundreds of pharmacy systems and hundreds of electronic health record (EHR) vendors depend on DrFirst’s innovative software solutions to improve clinical workflows, expedite secure collaboration across a patient’s care team and drive better health outcomes. The company’s integrated technologies include its award-winning electronic prescribing platform, the most comprehensive medication history available, clinically specialized secure messaging and patient medication adherence monitoring and benefits checking. Also, DrFirst was the first to offer e-prescribing for controlled substances (EPCS) and is considered the industry standard for providers nationwide. For more information, please visit www.drfirst.com or connect with us @DrFirst.
Press Contacts:
PDX Inc.
Miranda Nguyen
817-246-6760 ext. 4451
mnguyen@pdxinc.com
DrFirst
Jenn Cohen
Amendola Communications
404‐759‐3933
jcohen@acmarketingpr.com